Beck C. H. Arzneimittelgesetz

The Medicines Act is a central legal basis for the health protection of the population and regulates the relevant requirements for the handling of medicines by pharmaceutical industry, pharmacists and doctors. The large commentary on the Medicines Act explains the different subject areas of the law practically as well as legally sound and challenging. Particular emphasis is placed on the consideration of important European law requirements (especially RL 2001/83/ EC - Human Medicines Code) and the problems emerging in practice, which are discussed under comprehensive evaluation of the wide-ranging case law. In addition, the commentary impresses with a sophisticated systematic and a concise presentation that allows you to quickly find the desired problem and its solution. Benefits at a glance: Explanation oriented to the problems of practice. Comprehensive evaluation of the case law of the ECJ, BVerwG, BGH and upper courts Scientifically based commentary. Proof of the most important changes and European law requirements before each standard. For the new edition. In addition to new jurisprudence and literature, the new edition takes into account important changes in the law e.g. through the law on strengthening on-site pharmacies of 9.12.2020 (BGBl. I S. 2870), by the Third Population Protection Act of 18.11.2020 (BGBl. I S. 2397), by the Medical Devices EU Adaptation Act of 28.4.2020 (BGBl. I S. 960), by the Fairer Cash Competition Act of 22.3.2020 (BGBl. I S. 604), through the 2nd Data Protection Adaptation and Implementation Act EU, by the Act for More Safety in Medicine Supply of 9.8.2019 (BGBl. I S. 1202) and by the Act on Updating the Regulations for Blood and Tissue Preparations and Amending Other Regulations of 18.7.2017 (BGBl. I S. 2757). Target group: For judges and lawyers active in pharmaceutical law, corporate lawyers in the pharmaceutical industry, lawyers in pharmaceutical associations, health authorities, pharmacy chambers.